ClinTec Launches Global Academy of Clinical Research Excellence Focusing on Training Clinical Professionals
News Jun 08, 2010
ClinTec International announces the opening of its Global Academy of Clinical Research Excellence “ACRE”, at the 2010 PABME (Pharmaceutical and Biotechnology Middle East) conference in Dubai, UAE.
The ACRE training courses which have been accredited by the Dubai Health Authority have admitted the first students for training in ICH-GCP. The academy is set to provide the MENA region with a significant resource for training and educating professionals in clinical research techniques, methods and practices. The academy’s mission is to accelerate knowledge growth and to increase the level and quality of clinical research carried out in Middle East.
ClinTec has individually recruited and selected the academy’s staff. With plans to roll-out academies in other emerging markets such as India, China and Latin America, staff at ACRE have been selected for their local knowledge and understanding of the local clinical research market and its specific needs.
Dr Rabinder Buttar, CEO of ClinTec International commented: “A major healthcare challenge in the MENA region has been the capacity to develop the knowledge of local investigators to levels in which they fully understand the complex nuances required in international clinical trials. The most effective way to make clinical research more meaningful is to have a thorough knowledge of the processes and procedures involved in research. Our experience has shown that cultivating a learning curve is imperative for professional success.”
In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.READ MORE
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE